Man Group plc lifted its position in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 1.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 230,243 shares of the business services provider's stock after acquiring an additional 4,153 shares during the period. Man Group plc owned 0.45% of Exponent worth $20,515,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Barclays PLC grew its position in Exponent by 219.0% during the 3rd quarter. Barclays PLC now owns 96,526 shares of the business services provider's stock valued at $11,127,000 after purchasing an additional 66,263 shares during the last quarter. Allspring Global Investments Holdings LLC grew its holdings in shares of Exponent by 223.4% during the fourth quarter. Allspring Global Investments Holdings LLC now owns 6,158 shares of the business services provider's stock valued at $541,000 after buying an additional 4,254 shares during the last quarter. KBC Group NV increased its position in shares of Exponent by 62.4% during the fourth quarter. KBC Group NV now owns 2,274 shares of the business services provider's stock valued at $203,000 after acquiring an additional 874 shares in the last quarter. PineStone Asset Management Inc. lifted its stake in Exponent by 12.4% during the 4th quarter. PineStone Asset Management Inc. now owns 98,311 shares of the business services provider's stock valued at $8,760,000 after acquiring an additional 10,811 shares during the period. Finally, Empowered Funds LLC grew its position in Exponent by 28.8% in the 4th quarter. Empowered Funds LLC now owns 12,272 shares of the business services provider's stock worth $1,093,000 after purchasing an additional 2,747 shares during the period. Hedge funds and other institutional investors own 92.37% of the company's stock.
Insider Activity
In related news, VP Richard Reiss sold 1,736 shares of the company's stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $85.93, for a total transaction of $149,174.48. Following the sale, the vice president now owns 1,800 shares of the company's stock, valued at $154,674. This represents a 49.10% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 2.10% of the company's stock.
Exponent Price Performance
Shares of EXPO stock traded down $0.64 during trading hours on Tuesday, reaching $79.32. 234,525 shares of the company traded hands, compared to its average volume of 244,943. The firm has a 50-day moving average price of $79.22 and a 200 day moving average price of $87.63. The company has a market cap of $4.03 billion, a P/E ratio of 37.42 and a beta of 0.95. Exponent, Inc. has a 12-month low of $73.37 and a 12-month high of $115.75.
Exponent (NASDAQ:EXPO - Get Free Report) last released its earnings results on Thursday, May 1st. The business services provider reported $0.52 EPS for the quarter, topping analysts' consensus estimates of $0.48 by $0.04. Exponent had a net margin of 19.52% and a return on equity of 27.27%. The company had revenue of $137.44 million for the quarter, compared to analysts' expectations of $134.63 million. During the same quarter last year, the business earned $0.59 EPS. The firm's revenue was up .2% compared to the same quarter last year. Sell-side analysts predict that Exponent, Inc. will post 1.98 EPS for the current year.
Exponent Dividend Announcement
The firm also recently declared a quarterly dividend, which will be paid on Friday, June 20th. Shareholders of record on Friday, June 6th will be issued a dividend of $0.30 per share. The ex-dividend date is Friday, June 6th. This represents a $1.20 dividend on an annualized basis and a yield of 1.51%. Exponent's dividend payout ratio is presently 58.54%.
Exponent Company Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Recommended Stories

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.